System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Shuu-Jiun Wang is an expert in Neurology at Taipei Veterans General Hospital (Taiwan). As of October 2026, ScienceLeadR ranks Shuu-Jiun Wang in the top 1% of experts worldwide for Headache, Headache Disorders and Migraine Disorders. Shuu-Jiun Wang has authored 500 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 1,870 (community average: 125). How the SLR is computed.

LeadR Profile

Shuu-Jiun Wang Taipei Veterans General Hospital Taiwan
1 870 ScienceLeadR Reputation 1870

Unlock

Register Login
Network Map

Neurology

Subspecialties: Public Health - Physical Medicine - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Taipei Veterans General Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 500

Citations

Citations: 23 441 1st author: 28 Last author: 233 Unique author: 7

Main journals

Cephalalgia 110
J Headache Pain 58
J Chin Med Assoc 29
Headache 23
Curr Pain Headache Rep 19

Best Journals

Lancet Neurol 2
Nat Rev Dis Primers 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Identification of a resting-state functional brainstem network associated with trigeminal pain sensitivity and migraine.
PMID 42946982 — headache, pain, thalamus, migraine disorders, healthy volunteers, brain stem, pain threshold		J Headache Pain20260
2026 Taiwan guidelines for the acute pharmacologic treatment of migraine in adults.
PMID 42723131 — headache, pharmaceutical preparations, migraine disorders, acetaminophen, analgesics, tramadol, therapeutics		J Chin Med Assoc20260
Distinct brain metabolic patterns reflect biological heterogeneity and relate to clinical outcome in chronic migraine with medication overuse.
PMID 42578883 — headache, nucleus accumbens, brain, migraine disorders, cerebellum, putamen, therapeutics, prescription drug overuse		Cephalalgia20261
Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study.
PMID 42310529 — headache, safety, migraine disorders, therapeutics		J Headache Pain20260
Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific.
PMID 42293067 — headache, safety, pain, migraine disorders, surveys and questionnaires, diagnosis, therapeutics, child		Front Neurol20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

Phase 3 4
Phase 4 3
N/A 1

By status:

Completed 6
Recruiting 1
Unknown 1

By type:

Interventional 8

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 1
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Decoding Pain Sensitivity in Migraine With Multimodal Brainstem based Neurosignature
NCT04702971 — flunarizine, pain, brain, migraine disorders, connectome, brain stem		Phase 4Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS